W' granulomatosis ( WG) is a rare disease of (IL-6), epidermal growth factor ( EGF ), transforming growth factor beta ( TGF-b), prostaglandin E2 and unknown aetiology characterized by necrotizing vasculitis and granulomatous lesions affecting primarily the nitric oxide [9] . However, the major inducer of VEGF expression is hypoxia [8] . VEGF expression is detectupper and lower respiratory tract. As the disease progresses, other organs also become involved, most able in areas where EC are proliferating and also around microvessels in areas where EC are normally commonly the kidneys, skin, eyes, joints and nervous system [1] . The detection of autoantibodies in the quiescent [10] . In homozygous mice deficient for VEGF expression, the formation of blood vessels is patient's sera and a good response to immunosuppressive therapy suggest an autoimmune background to severely impaired [11, 12] , whereas overexpression of VEGF in quail resulted in hypervascularity and hyperthe disease. A majority of WG patients have classic antineutrophil cytoplasmic antibodies (c-ANCA) [2] , permeability [13] . VEGF mRNA is expressed in brain, kidney, lung, liver and spleen in the adult rat, with the most common c-ANCA in WG being antiproteinase 3 antibodies. However, c-ANCA are not expression being highest in the lung. Continued expression of VEGF in adult animal tissues suggests that it specific for WG nor are all WG patients c-ANCA positive. Primary vasculitis and granuloma formation may play a role in the maintenance of normal vessel physiology, which may be disturbed in patients with are the predominant features of WG, and are the result of a chronic inflammatory reaction that involves the WG. In view of the above functions of VEGF, we hypothesized that it may be important in the pathobiolendothelium. Measurement of the inflammatory activity is not precise; von Willibrand factor (vWF ), erythogy of WG. In the present study, we have measured the VEGF levels in the serum from 23 patients with rocyte sedimentation rate ( ESR) and C-reactive protein (CRP) have been used, but may not be reliable [2] [3] [4] [5] [6] [7] .
active WG, 21 healthy subjects and 25 patients with urinary infection. The correlation of the serum VEGF Vascular endothelial growth factor ( VEGF ) is an endothelial cell ( EC ) mitogen in vitro and a potent levels with the activity of WG was assessed. angiogenic factor in vivo [8] . It exerts its effects through two endothelial cell receptors, the tyrosine kinases METHODS Flk-1/KDR and Flt-1, which are important in the clinically active and was classified as major or minor disease activity as described previously [15] . Briefly, light emission were converted into absolute concentrations by reference to the VEGF standard curve. minor disease activity in WG was defined as active lesions of WG in the upper or lower airways without any evidence of vasculitic activity in other organs.
Statistical analysis Data presented are the mean ± ... For comMajor disease activity was defined as renal involvement parison between groups, Student's t-test was used. leading to deteriorating renal function with red blood Correlation of VEGF with disease activity, ANCA cell casts or biopsy-proven necrotizing glomeruloand other parameters was assessed by the Pearson test. nephritis, pulmonary involvement with impending res-A P value (two-tailed ) of ∏ 0.05 was considered piratory failure, cerebral vasculitis, or acute abdominal significant. or massive gastrointestinal haemorrhage due to vasculitis. In addition, vascular activity and damage were RESULTS also scored using criteria described by the Birmingham VEGF levels in WG, normal and disease controls group [3] [4] [5] . Of the 23 WG patients, 83% (19/23) were VEGF levels (mean ± ...) from the 21 normal c-ANCA positive. Male to female ratios in controls subjects were 1.02 ± 0.25 ng/ml (range 0.14-3.94). In and WG patients were 10:11 and 16:7, respectively. WG patients, VEGF levels were 34.76 ± 6.78 ng/ml The median duration of disease with major and minor (range 1.2-80.0) and were significantly increased comdisease activities was 13 yr (range 2-35 yr) and 10 yr pared to controls (P < 0.0001). With a cut-off value (range 1-12 yr), respectively. Treatment at the time of of 3.3 ng/ml (this value being the mean + 2 .. of the the sample was also recorded. Twenty-one serum VEGF levels in normal subjects), 91.3% (21/23) of the samples were taken from age-matched volunteers as WG patients had VEGF levels above the cut-off level normal controls. Sera from 25 hospitalized patients ( Fig. 1 ). To assess whether the serum levels of VEGF with urinary infection were used as non-vascular disare affected by infection, sera from 25 patients with ease controls. Thirty-seven rheumatoid arthritis (RA) urinary infection were used to measure the VEGF samples were used as controls for inflammation. Serum samples were aliquoted and stored at −70°C until the assay was performed.
Measurement of VEGF
Measurement of VEGF levels in sera from patients and controls was carried out at the same time. An ELISA for VEGF was established using commercial antibodies against VEGF. The use of enhanced chemiluminescence increased the sensitivity of the assay by 30-fold compared to colorimeric ELISA and had interand intra-assay variations of <7%. For this assay, 96-well white plates (Dynatech Microfluor, USA) were coated with 100 ml/well of goat anti-VEGF 165 antibody (R&D systems) diluted 1/1000 (1 mg/ml ) in 0.1  carbonate buffer (pH 9.6), and incubated in a humid box overnight at 4°C. The coated plates were blocked with 1% (w/v) bovine serum albumin (BSA), 0.01% (v/v) Tween 20 in 0.1  phosphate-buffered saline (PBSTween) for 2 h at room temperature. Duplicate serum samples were added to the plates (100 ml/well, diluted 1/2 in PBS-Tween). A standard curve was generated using recombinant human VEGF (R&D Systems) at a range of 0.1-40 ng/ml on each plate. After overnight incubation at 4°C, 100 ml/well of rabbit anti-VEGF antibody (Santa Cruz Biotechnology) were added to the plates at 1/2000 dilution (1 mg/ml ) in PBS-Tween and incubated for 3 h at 4°C. This was followed by the addition of horseradish peroxidase-conjugated goat anti-rabbit antibody (0.5 mg/ml ) (diluted 1/2000 with 1% BSA in PBS-Tween), which was incubated with steps. Finally, 100 ml/well of Amerlite chemilumines-VEGF levels were significantly elevated in WG patients (+, patients cence signal reagent (Amersham, UK ) were added and with major disease activity; $, patients with minor disease activity) the plates were read immediately in a plate reader compared to normal controls. Seven patients with WG had VEGF levels >80 ng/ml.
( Kodak Clinical Diagnostics). The measured values of levels. The results indicated that serum VEGF DISCUSSION was similar in individuals with urinary infection This is the first report which demonstrates high (1.35 ± 0.60 ng/ml, range 0-15.08) and normal indilevels (up to 80-fold increase) of VEGF in serum viduals (P > 0.05), but was lower than in WG samples from WG patients. Furthermore, the increased (P < 0.0001). To test the hypothesis that increased levels of VEGF correlated with the disease activity. VEGF levels are a marker of inflammation rather than
These results imply that VEGF may play an important a WG-specific marker, VEGF levels were measured in role in the pathobiology of WG. 37 RA patients (14 with high CRP levels and 23 with
The source of the elevated VEGF in WG patients is low CRP levels). The results showed that while VEGF a matter of speculation. The data from urinary infeclevels in RA (13.59 ± 4.97 ng/ml ) were higher than tion which showed no increase in VEGF levels ruled normal controls, the increase was not significant out the possibility that the markedly elevated VEGF (P > 0.01). When VEGF levels in RA were compared resulted from infection, such as might occur as a to VEGF levels in WG, they were significantly lower secondary phenomenon in patients with vasculitis. In (P = 0.0057). There was no difference in VEGF levels the absence of immunohistochemistry and in situ data, between low (11.07 ± 5.7 ng/ml ) and high (17.74 V it is not possible to define the cellular origin of VEGF 9.02 ng/ml ) CRP levels (P > 0.01), indicating that in WG patients, although the published literature increased VEGF levels are not a marker of suggested that VEGF is produced by numerous inflammation.
cell types, including macrophages, T cells, kidney cells and keratinocytes [9] . Among these cells, T cells and macrophages are predominantly present in the Correlation between VEGF levels and disease activity inflammatory infiltrates in WG and thus may be a Correlation analysis of the data showed that VEGF source of increased VEGF. Several studies have demlevels did not correlate with age, sex, c-ANCA or onstrated that hypoxia plays a major role in moduduration of the disease (P > 0.05), but correlated well lating VEGF expression [8, 17] . In glioblastoma with major and minor disease status (r = 0.51, multiforme and other tumours with a significant nec-P < 0.01): markedly elevated VEGF levels were rotic component, VEGF mRNA is highly expressed in observed in patients with major (47.67 ± 9.41 ng/ml ) ischaemic tumour cells present in the areas of necrosis compared to minor disease activity (14.67 ± [18] . Likewise, in human stroke tissues, in ischaemic 4.11 ng/ml ) (P < 0.01). All the highest values for and repairing zones, high levels of VEGF protein and VEGF (Á80 ng/ml ) belonged to patients with major mRNA have been reported (R. Issa, personal communidisease activity ( Fig. 1) . VEGF data were further cation). Ischaemia caused by occlusion of the coronary analysed for their correlation with vasculitis activity artery results in a dramatic increase in VEGF mRNA as proposed by the Birmingham group [3] [4] [5] , wherein levels in the pig myocardium, which again suggests scores for activity and damage are allocated. Using that local hypoxia is an important inducer of VEGF Pearson's correlation test, no significant correlation [19] . Increased VEGF levels in the circulation have was detected with either the score for activity (r = 0.15, also been reported in a number of diseases, such as P = 0.54) or damage (r = 0.27, P = 0.24). stroke (R. Issa, personal communication) and solid tumours [20] . Therefore, VEGF does not seem to be specific for a particular disease, but probably is a nonCorrelation of c-ANCA with VEGF and disease specific marker for vascular disorders in which EC activity damage/repair occurs. The tests for ANCA were carried out by indirect Until recently, vascular endothelium was regarded immunofluorescence using normal human neutrophils purely as the victim of vasculitic processes in WG. It [2, 6 ] . Immunofluorescence, when seen, was in all cases is now becoming apparent that EC play an initiating cytoplasmic (the staining pattern characteristic of role in vascular damage. Exposure of EC to cytokines c-ANCA, where the autoantigen is usually proteinase such as IL-1, tumour necrosis factor alpha and 3) [16 ] . Correlation analysis showed that neither the lymphotoxin causes increased procoagulant activity, occurrence nor the levels of serum c-ANCA correlated adhesiveness for various inflammatory cells, and the with VEGF concentrations (r = − 0.25, P = 0.34 and release of prostacyclins and platelet-derived growth r = − 0.42, P = 0.08, respectively). Furthermore, no factor. Furthermore, upregulation of VEGF may cause significant correlation was established between the increased vascular permeability, which could contriboccurrence or levels of c-ANCA and disease status ute to the transmigration of the inflammatory cells assessed as major or minor or by the Birmingham through the vessel wall and the extravasation of plasma activity scale [3] [4] [5] .
proteins from leaky vessels. The latter may lead to the exposure of potential antigens normally sequestered inside the EC and consequently the production of Correlation of treatment with VEGF levels There was no difference in VEGF levels between anti-EC antibodies, often present in WG, which are capable of activating EC and facilitating leucocyte patients undergoing treatment and those receiving no treatment. Prednisolone, cyclophosphamide and azarecruitment and adhesion to endothelium [21] . It has also been shown that VEGF augments the expression thioprine had no effect on VEGF levels in WG patients.
